Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Occupational Carcinogens Collaborators.

Occup Environ Med. 2020 Mar;77(3):151-159. doi: 10.1136/oemed-2019-106012.

2.

Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Occupational Chronic Respiratory Risk Factors Collaborators; GBD 2016 occupational chronic respiratory risk factors collaborators.

Occup Environ Med. 2020 Mar;77(3):142-150. doi: 10.1136/oemed-2019-106013.

3.

Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Occupational Risk Factors Collaborators.

Occup Environ Med. 2020 Mar;77(3):133-141. doi: 10.1136/oemed-2019-106008.

4.

Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017.

GBD 2017 Diarrhoeal Disease Collaborators.

Lancet Infect Dis. 2020 Jan;20(1):37-59. doi: 10.1016/S1473-3099(19)30401-3. Epub 2019 Oct 31.

5.

Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017.

GBD 2017 Lower Respiratory Infections Collaborators.

Lancet Infect Dis. 2020 Jan;20(1):60-79. doi: 10.1016/S1473-3099(19)30410-4. Epub 2019 Oct 31.

6.

Improving and Expanding Estimates of the Global Burden of Disease Due to Environmental Health Risk Factors.

Shaffer RM, Sellers SP, Baker MG, de Buen Kalman R, Frostad J, Suter MK, Anenberg SC, Balbus J, Basu N, Bellinger DC, Birnbaum L, Brauer M, Cohen A, Ebi KL, Fuller R, Grandjean P, Hess JJ, Kogevinas M, Kumar P, Landrigan PJ, Lanphear B, London SJ, Rooney AA, Stanaway JD, Trasande L, Walker K, Hu H.

Environ Health Perspect. 2019 Oct;127(10):105001. doi: 10.1289/EHP5496. Epub 2019 Oct 18.

7.

The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Non-Typhoidal Salmonella Invasive Disease Collaborators.

Lancet Infect Dis. 2019 Dec;19(12):1312-1324. doi: 10.1016/S1473-3099(19)30418-9. Epub 2019 Sep 24.

8.

The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Typhoid and Paratyphoid Collaborators.

Lancet Infect Dis. 2019 Apr;19(4):369-381. doi: 10.1016/S1473-3099(18)30685-6. Epub 2019 Feb 18.

9.

The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017.

India State-Level Disease Burden Initiative Air Pollution Collaborators.

Lancet Planet Health. 2019 Jan;3(1):e26-e39. doi: 10.1016/S2542-5196(18)30261-4. Epub 2018 Dec 6.

12.
15.

Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Lower Respiratory Infections Collaborators.

Lancet Infect Dis. 2018 Nov;18(11):1191-1210. doi: 10.1016/S1473-3099(18)30310-4. Epub 2018 Sep 19.

16.

Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Diarrhoeal Disease Collaborators.

Lancet Infect Dis. 2018 Nov;18(11):1211-1228. doi: 10.1016/S1473-3099(18)30362-1. Epub 2018 Sep 19.

17.

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.

GBD 2016 Healthcare Access and Quality Collaborators.

Lancet. 2018 Jun 2;391(10136):2236-2271. doi: 10.1016/S0140-6736(18)30994-2. Epub 2018 Jun 1.

18.

Could violent conflict derail the London Declaration on NTDs?

Du RY, Stanaway JD, Hotez PJ.

PLoS Negl Trop Dis. 2018 Apr 19;12(4):e0006136. doi: 10.1371/journal.pntd.0006136. eCollection 2018 Apr. No abstract available.

19.

Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study.

Lo NC, Gupta R, Stanaway JD, Garrett DO, Bogoch II, Luby SP, Andrews JR.

J Infect Dis. 2018 Nov 10;218(suppl_4):S232-S242. doi: 10.1093/infdis/jix598.

20.

Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.

Shearer FM, Longbottom J, Browne AJ, Pigott DM, Brady OJ, Kraemer MUG, Marinho F, Yactayo S, de Araújo VEM, da Nóbrega AA, Fullman N, Ray SE, Mosser JF, Stanaway JD, Lim SS, Reiner RC Jr, Moyes CL, Hay SI, Golding N.

Lancet Glob Health. 2018 Mar;6(3):e270-e278. doi: 10.1016/S2214-109X(18)30024-X. Epub 2018 Feb 2.

Supplemental Content

Loading ...
Support Center